Regulus CVR may be worth $3-$4 a share in Novartis deal - analyst

Stock Information for Regulus Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Regulus Therapeutics Inc.

Natural Gas Services Group, Inc. Reports Third Quarter 2025 Financial and Operating Results; Increases 2025 Adjusted EBITDA Guidance
Natural Gas Services Group, Inc. Announces Reporting Date for its Q3 2025 Earnings Conference Call
Natural Gas Services Group, Inc. Reports Second Quarter 2025 Financial and Operating Results;
Natural Gas Services Group, Inc. Initiates First Quarterly Dividend
ePlus Enters Into Agreement to Sell Financing Business to PEAC, a Portfolio Company of HPS Investment Partners, LLC
Natural Gas Services Group, Inc. Announces Transition of Stephen C. Taylor to Chairman Emeritus and Appointment of Donald J. Tringali as Chairman of the Board
Sidoti Events, LLC's Virtual May Micro-Cap Conference
Natural Gas Services Group, Inc. Reports First Quarter 2025 Financial and Operating Results; Increases 2025 Guidance

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.